Search for clinical trials.
A Focus On Science
NRG Oncology and its partners have more than 150 years experience in conducting practice-defining, multi-institutional phase II and III trials sponsored primarily by the National Cancer Institute (NCI), as well as a history of undertaking the kind of phase I trials and translational biological studies that will be imperative for future clinical cancer research.
Our Mission
Improve the lives of patients with cancer by conducting practice-changing multi-institutional clinical and translational research
Dr. Robert S. Mannel
Our exceptional network brings individuals together who are passionate about changing the future of cancer care through impactful clinical trials.
Membership Resources
NRG Oncology’s membership roster is comprised of over 1,000 member sites including institutions on five continents. Our investigators represent all of the oncologic medical specialties and disciplines.
Learn MoreLatest News
NRG Oncology Adds New Leadership Members to Brain Tumor, Breast Cancer, Genitourinary Cancer, Lung Cancer, Medical Oncology, Medical Physics, Protocol Operations Monitoring, Publications, and Translational Science Committees
NRG Oncology (NRG), a National Cancer Institute (NCI) National Clinical Trials Network (NCTN) group focused on improving outcomes for adults with cancer through multi-center clinical research, recently announced changes in leadership across multiple committees.
NRG Oncology seeks to fill the position of Vice Chair NRG Oncology Sarcoma Subcommittee
The NRG Oncology Sarcoma Subcommittee is a subcommittee of the Developmental Therapeutics Committee, one of four Non-Disease Site Committees which conduct NRG Oncology trials as well as support research within the disease site committees.
NRG Oncology seeks to fill the position of Chair of the Investigator & Career Development (ICD) Committee.
Application Deadline: February 16, 2026
Stay current with science. Sign up for our newsletter.
Support NRG Oncology.
Help Our Cause.
We are a leading protocol organizations within the National Clinical Trials Network and we seek to improve the lives of cancer patients by conducting practice-changing, multi-institutional clinical and translational research. Learn More